53
Views
5
CrossRef citations to date
0
Altmetric
Review

Potential of afatinib in the treatment of patients with HER2-positive breast cancer

, , &
Pages 131-137 | Published online: 27 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jian Wang, Yuxin Wen, Guanggui Ding, Peikun Ding, Lu Zhang, Jing Liu, Tengfei Zhang & Lin Yang. (2018) Efficacy generated by afatinib in a lung adenocarcinoma patient harboring HER2 S310Y mutation. Cancer Biology & Therapy 19:6, pages 450-453.
Read now
Andrea Milani, Dario Sangiolo, Massimo Aglietta & Giorgio Valabrega. (2014) Recent advances in the development of breast cancer vaccines. Breast Cancer: Targets and Therapy 6, pages 159-168.
Read now

Articles from other publishers (3)

ARUN KUMAR. (2021) COMPREHENSIVE REVIEW ON ETIOPATHOGENESIS, TREATMENT AND EMERGING THERAPIES OF BREAST CANCER. Asian Journal of Pharmaceutical and Clinical Research, pages 20-33.
Crossref
Sumayah Al-Mahmood, Justin Sapiezynski, Olga B. Garbuzenko & Tamara Minko. (2018) Metastatic and triple-negative breast cancer: challenges and treatment options. Drug Delivery and Translational Research 8:5, pages 1483-1507.
Crossref
Zhen Xiang, Xia Huang, Jiexuan Wang, Jun Zhang, Jun Ji, Ranlin Yan, Zhenggang Zhu, Wei Cai & Yingyan Yu. (2018) Cross-Database Analysis Reveals Sensitive Biomarkers for Combined Therapy for ERBB2+ Gastric Cancer. Frontiers in Pharmacology 9.
Crossref